Insider · CIK 0001684258

Gross Jane A

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001684258

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-11	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-05-01	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-03-17	ATYRaTYR PHARMA INCP Purchase	Director	PPurchase	+3,750 sh	$4.00	+$15K	9,750
2024-05-22	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2023-05-17	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-04-26	ATYRaTYR PHARMA INCM Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	—	—	6,000
2023-04-26	ATYRaTYR PHARMA INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2022-04-26	ATYRaTYR PHARMA INC · Restricted Stock UnitsA Award	Director	AAward	+6,000 sh	—	—	6,000
2021-04-28	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+1,428 sh	—	—	1,428
2021-01-29	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	SVP & Chief Scientific Officer	AAward	+5,500 sh	—	—	5,500
2021-01-29	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+16.5K sh	—	—	16,500
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−4,814 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−2,072 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−2,779 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−3,908 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−2,407 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−2,407 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	SVP & Chief Scientific Officer	DDisposition to Issuer	−4,814 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+7,784 sh	—	—	7,784
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+2,140 sh	—	—	2,140
2020-05-06	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+1,428 sh	—	—	1,428
2020-02-18	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+135K sh	—	—	134,800
2019-11-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+123K sh	—	—	122,982
2019-06-28	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+2,285 sh	—	—	2,285
2019-03-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−9,138 sh	—	—	0
2019-03-01	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−2,710 sh	$1.57	−$4,254.7	109,583
2019-03-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+9,138 sh	—	—	112,293
2019-02-28	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+67.4K sh	—	—	67,400
2018-03-09	APVOAptevo Therapeutics Inc. · Employee Stock Options (Right to Buy)A Award	SVP & Chief Scientific Officer	AAward	+67.4K sh	—	—	67,400
2018-03-09	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+9,728 sh	—	—	105,437
2018-03-09	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−2,282 sh	$3.13	−$7,142.66	103,155
2018-03-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−9,728 sh	—	—	9,138
2018-03-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+9,140 sh	—	—	95,709
2018-03-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−9,140 sh	—	—	18,866
2018-02-03	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−18.1K sh	—	—	28,006
2018-02-03	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+18.1K sh	—	—	86,569
2017-08-01	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−10.1K sh	$1.83	−$18.4K	68,433
2017-08-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−38.1K sh	—	—	46,142
2017-08-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+38.1K sh	—	—	78,509
2017-06-01	APVOAptevo Therapeutics Inc. · Employee Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+33.7K sh	—	—	33,700
2017-03-10	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+14.5K sh	—	—	44,253
2017-03-10	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−14.5K sh	—	—	84,235
2017-03-10	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−3,837 sh	$1.78	−$6,829.86	40,416
2017-03-09	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+9,727 sh	—	—	32,320
2017-03-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−9,727 sh	—	—	98,741
2017-03-09	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−2,573 sh	$1.80	−$4,631.4	29,747
2017-03-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	+9,140 sh	—	—	25,011
2017-03-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	SVP & Chief Scientific Officer	MExercise/Conversion	−9,140 sh	—	—	108,468
2017-03-01	APVOAptevo Therapeutics Inc.F Tax Payment	SVP & Chief Scientific Officer	FTax Payment	−2,148 sh	$2.02	−$4,338.96	22,593
2017-02-24	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+33.7K sh	—	—	156,339

Recent filings

Accepted (ET)
May 134
Gross Jane A0001684258-26-000003
SEC(opens sec.gov)
May 24
Gross Jane A0000950170-25-062937
SEC(opens sec.gov)
Mar 174
Gross Jane A0000950170-25-040600
SEC(opens sec.gov)
May 234
Gross Jane A0000950170-24-064229
SEC(opens sec.gov)
May 194
Gross Jane A0001209191-23-031012
SEC(opens sec.gov)
Apr 284
Gross Jane A0001209191-23-026064
SEC(opens sec.gov)
Apr 284
Gross Jane A0001209191-22-026089
SEC(opens sec.gov)
Apr 294
Gross Jane A0001209191-21-029121
SEC(opens sec.gov)
Feb 174
Gross Jane A0001019056-21-000142
SEC(opens sec.gov)
Jul 314
Gross Jane A0001019056-20-000451
SEC(opens sec.gov)

Companies

Address

C/O ATYR PHARMA, INC. 10240 SORRENTO VALLEY ROAD, SUITE 300

SAN DIEGO, CA, 92121